Merck leads biopharmas in annual ‘just’ business ranking, while GSK and Sanofi nab sustainability honors
When it comes to best-business behaviors, Merck is leading pharma and biotech companies, according to the annual Just Capital list of 100 public company standouts this week. Merck came in first in the industry and at No. 26 overall, followed by Illumina (28), Biogen (41) and Amgen (100) in the general ranking spanning more than 30 different vertical business categories. Falling just outside the top group were Johnson & Johnson (101), Regeneron (109) and Gilead Sciences (112).
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,800+ biopharma pros reading Endpoints daily — and it's free.